Where do we go after GiACTA?
Rheumatology (Oxford)
.
2022 Jul 6;61(7):2720-2721.
doi: 10.1093/rheumatology/keac010.
Authors
Michael Putman
1
,
Sebastian Sattui
2
,
Richard Conway
3
Affiliations
1
Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
2
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
3
Department of Rheumatology, St James's Hospital, Dublin, Ireland.
PMID:
35020808
DOI:
10.1093/rheumatology/keac010
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Giant Cell Arteritis*
Humans
Recurrence
Substances
Antibodies, Monoclonal, Humanized
tocilizumab